Slaby O - Search Results

1

MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma.

Redova M, Poprach A, Besse A, Iliev R, Nekvindova J, Lakomy R, Radova L, Svoboda M, Dolezel J, Vyzula R, Slaby O. Redova M, et al. Among authors: slaby o. Tumour Biol. 2013 Feb;34(1):481-91. doi: 10.1007/s13277-012-0573-2. Epub 2012 Nov 13. Tumour Biol. 2013. PMID: 23150176

2

Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer.

Slaby O, Svoboda M, Fabian P, Smerdova T, Knoflickova D, Bednarikova M, Nenutil R, Vyzula R. Slaby O, et al. Oncology. 2007;72(5-6):397-402. doi: 10.1159/000113489. Epub 2008 Jan 15. Oncology. 2007. PMID: 18196926 Clinical Trial.

3

[Involvement of microRNAs in cancer biology and possibilities of their application to diagnostic and predictive oncology].

Slabý O, Krekác D, Hrstka R, Svoboda M, Vyzula R. Slabý O, et al. Cas Lek Cesk. 2008;147(1):25-31. Cas Lek Cesk. 2008. PMID: 18323039 Review. Czech.

4

[Gene expression profiling in prediction of tumor response to neoadjuvant concomitant chemoradiotherapy in patients with locally advanced rectal carcinoma: pilot study].

Garajová I, Slabý O, Svoboda M, Fabian P, Silák J, Smerdová T, Kocák I, Růzicková J, Hoch J, Vyzula R. Garajová I, et al. Among authors: slaby o. Cas Lek Cesk. 2008;147(7):381-6. Cas Lek Cesk. 2008. PMID: 18678097 Slovak.

5

Significant overexpression of Hsp110 gene during colorectal cancer progression.

Slaby O, Sobkova K, Svoboda M, Garajova I, Fabian P, Hrstka R, Nenutil R, Sachlova M, Kocakova I, Michalek J, Smerdova T, Knoflickova D, Vyzula R. Slaby O, et al. Oncol Rep. 2009 May;21(5):1235-41. doi: 10.3892/or_00000346. Oncol Rep. 2009. PMID: 19360299

6

[Possibilities of resistance prediction to neoadjuvant concomitant chemoradiotherapy in the treatment algorithm of patients with rectal carcinoma].

Garajová I, Svoboda M, Slabý O, Kocáková I, Fabian P, Kocák I, Vyzula R. Garajová I, et al. Among authors: slaby o. Klin Onkol. 2008;21(6):330-7. Klin Onkol. 2008. PMID: 19382596 Review. Slovak.

7

MicroRNA involvement in glioblastoma pathogenesis.

Novakova J, Slaby O, Vyzula R, Michalek J. Novakova J, et al. Among authors: slaby o. Biochem Biophys Res Commun. 2009 Aug 14;386(1):1-5. doi: 10.1016/j.bbrc.2009.06.034. Epub 2009 Jun 11. Biochem Biophys Res Commun. 2009. PMID: 19523920 Review.

8

[DNA and microRNA microarray technologies in diagnostics and prediction for patients with renal cell carcinoma].

Slabý O, Svoboda M, Michálek J, Vyzula R. Slabý O, et al. Klin Onkol. 2009;22(5):202-9. Klin Onkol. 2009. PMID: 19886357 Review. Czech.

9

MicroRNAs in colorectal cancer: translation of molecular biology into clinical application.

Slaby O, Svoboda M, Michalek J, Vyzula R. Slaby O, et al. Mol Cancer. 2009 Nov 14;8:102. doi: 10.1186/1476-4598-8-102. Mol Cancer. 2009. PMID: 19912656 Free PMC article. Review.

10

Expression pattern of HLA class I antigens in renal cell carcinoma and primary cell line cultures: methodological implications for immunotherapy.

Hanak L, Slaby O, Lauerova L, Kren L, Nenutil R, Michalek J. Hanak L, et al. Among authors: slaby o. Med Sci Monit. 2009 Dec;15(12):CR638-43. Med Sci Monit. 2009. PMID: 19946235

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

359 results

Search Page

Filters